529 filings
Page 4 of 27
8-K
xdf 0w57qufulm
8 May 23
Syndax Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Business Update
4:07pm
DEFA14A
lxjxfn10trg mqgub8
18 Apr 23
Additional proxy soliciting materials
4:00pm
4
7jj4x6fuzo3ue
12 Apr 23
Syndax Pharmaceuticals / Briggs Morrison ownership change
4:03pm
4
ezmhqms 7buwgvpn
12 Apr 23
Syndax Pharmaceuticals / Neil Gallagher ownership change
4:02pm
3
fkgcexwzgw8cwrf
12 Apr 23
Syndax Pharmaceuticals / Neil Gallagher ownership change
4:01pm
ARS
d033a hr6gmxvv4z
7 Apr 23
Annual report to shareholders
4:05pm
DEFA14A
lbpzy2jy5kue3j
7 Apr 23
Additional proxy soliciting materials
4:02pm
8-K
k28 qkh54stu
30 Mar 23
Syndax Pharmaceuticals Announces Appointment of Neil Gallagher, M.D., Ph.D. as President, Head of Research and Development
8:00am
PRE 14A
5dys4ip e3gn
28 Mar 23
Preliminary proxy
4:15pm
4
t05ysm0wkuz
14 Mar 23
Syndax Pharmaceuticals / Briggs Morrison ownership change
4:42pm
S-8
ccvyf8
28 Feb 23
Registration of securities for employees
4:15pm
8-K
lf0ashyg30i1txdahyax
28 Feb 23
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business Update
4:06pm
4
zgy5rzqz kultliu
17 Feb 23
Syndax Pharmaceuticals / Peter Ordentlich ownership change
6:09pm
SC 13G/A
1ivm 7z4jxd
14 Feb 23
Syndax Pharmaceuticals / Nantahala Capital Management ownership change
4:46pm
SC 13G/A
wt1s7ir62cyfyitz
14 Feb 23
Syndax Pharmaceuticals / Avidity Partners Management ownership change
3:47pm
SC 13G/A
c447t 2uy9lhz
14 Feb 23
Syndax Pharmaceuticals / Frazier Life Sciences Public Fund ownership change
12:12pm
SC 13G/A
5a4xltww jf2u
14 Feb 23
Syndax Pharmaceuticals / BIOTECHNOLOGY VALUE FUND L P ownership change
11:53am